Related Experiment Video
Updated: Jul 25, 2026

Fused Filament Fabrication FFF of Metal-Ceramic Components
Published on: January 11, 2019
Continuous manufacturing via hot-melt extrusion and scale up: regulatory matters
Mohammed Maniruzzaman1, Ali Nokhodchi2
1Pharmaceutics Research Laboratory, Arundel Building, School of Life Sciences, University of Sussex, Brighton BN1 9QJ, UK.
Abstract:
Currently, because globalization, the pharmaceutical industry is facing enormous challenges to comply with regulatory matters. Reduced patent life and overall decreased profitability of newly discovered drugs are also forcing the pharmaceutical industry to shorten the drug development time with maximum throughput. Therefore, continuous manufacturing (CM) processes via hot melt extrusion (HME) can be a promising alternative for achieving these goals. HME offers solvent-free green technology with a process that is easy to scale up. Moreover, CM provides better product quality assurance compared with batch processes, with fewer labor costs and shorter time to development. In this review, we primarily focus on various aspects of CM and the emerging application of HME to bridge the current manufacturing gap in pharmaceutical sphere.
Related Concept Videos
Steel Manufacturing
During this smelting process, limestone plays a crucial role by forming slag. Slag captures impurities within the molten iron, such...
Structural Steel Products
Once shaped, the steel's final form emerges as a continuous length, which is then segmented by a hot saw into manageable pieces. These segments are...
Good Manufacturing Practices
Scale-Up Processes
Upstream Processing

